Creation of a suppressive microenvironment by macrophages and cancer-associated fibroblasts

Frontiers in Bioscience

Volumn 18, Issue 3, 2013, Pages 1003-1016

  Dutsch Wicherek, Magdalena ^a   Kazmierczak, Wojciech ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cancer; Fibroblast; Macophage; Microenvironment; Neoplasms; Review; Suppressive; Tumor

Indexed keywords

EID: 84880538132     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4159     Document Type: Article

References (125)

1. Balkwill F.& A. Mantovani: Inflammation and cancer: back to Virchow? This paper revisits Virchow's legacy and highlights the connections between inflammation and cancer. Lancet 357, 539-545 (2001).
2. Mantovani A., P. Allavena, A. Sica & F. Balkwill: Cancer-related inflammation. Nature 454, 436-444 (2008).
3. Mantovani A., P. Romero, A.K. Palucka & F.M. Marincola: Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 371, 771-783 (2008).
4. Mantovani A.: Cancer: Inflammation by remote control. Nature 435, 752-753 (2005). (Pubitemid 40839716)
5. De Visser K.E., L.V. Korets & L.M. Coussens: De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7, 411-423 (2005). (Pubitemid 40719125)
6. Old L.J. & Y.T. Chen: New paths in human cancer serology. J. Exp. Med. 187, 1163-1167 (1998). (Pubitemid 28189106)
7. Ganss R. & D. Hanahan: Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. Cancer Res.58, 4673-4681 (1998). (Pubitemid 28480634)
8. Andres A: Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit. Rev. Oncol. Hematol. 56, 71-85 (2005). (Pubitemid 41278647)
9. Ippoliti G., M. Rinaldi, C. Pellegrini & M. Vigano: Incidence of cancer after immunosuppressive treatment for heart transplantation. Crit. Rev. Oncol. Hematol. 56, 101-113 (2005). (Pubitemid 41278649)
10. Shankaran V., H. Ikeda, A.T. Bruce, J.M. White, P.E. Swanson, L.J. Old, R.D. Schreiber: IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107-1111 (2001). (Pubitemid 32391043)
11. Dunn G.P., L.J. Old & R.D. Schreiber: The three Es of cancer immunoediting. Annu. Rev. Immunol. 22, 329-360 (2004). (Pubitemid 38680426)
12. Aggarwal B.B., S. Shishodia, S.K. Sandur, M.K. Pandey & G. Sethi: Inflammation and cancer: How hot is the link? Biochem. Pharmacol. 72, 1605-1621 (2006). (Pubitemid 44666739)
13. Bilton R.L.& G.W. Booker: The subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur. J. Biochem. 270, 791-798 (2003). (Pubitemid 36315322)
14. Metzen E.& P.J. Ratcliffe P.J.: HIF hydroxylation and cellular oxygen sensing. BiolChem 385, 223-320 (2004).
15. Hellwig-Burgel T., D.P. Stiehl, A.E. Wagner, E. Metzen, W. Jelkmann: Review: hypoxia-inducible factor-1 (HIF-1): A novel transcription factor in immune reactions. J. Interferon Cytokine Res. 25, 297-310 (2005). (Pubitemid 40911381)
16. Czekay R.P., K. Aertgeerts, S.A. Curriden, D.J. Loskutoff: Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J. Cell Biol. 160, 781-791 (2003). (Pubitemid 36298272)
17. Koong A.C., N.C. Denko, K.M. Hudson, C. Schindler, L. Swiersz, C. Koch, S. Evans, H. Ibrahim, Q.T. Le, D.J. Terris & A.J. Giaccia: Candidate genes for the hypoxic tumor phenotype. Cancer Res. 60, 883-887 (2000). (Pubitemid 30129520)
18. Schioppa T., B. Uranchimeg, A. Saccani, S.K. Biswas, A. Doni, A. Rapisarda, S. Bernasconi, S. Saccani, M. Nebuloni, L. Vago, A. Mantovani, G. Melillo & A. Sica: Regulation of the chemokine receptor CXCR4 by hypoxia J. Exp. Med. 198, 1391-1402 (2003). (Pubitemid 37392484)
19. Babior B.M.: Phagocytes and oxidative stress. Am. J. Med. 109, 33-44 (2000). (Pubitemid 30608735)
20. Robinson S.C.& L.M. Coussens: Soluble mediators of inflammation during tumor development. Adv. Cancer Res. 93, 159-187 (2005).
21. Allavena P., A. Sica, C. Garlanda & A. Mantovani: The yin-yang of tumorassociated macrophages in neoplastic progression and immune surveillance. Immunol. Rev. 222, 155- 161 (2008). (Pubitemid 351430369)
22. Benelli R., G. Lorusso, A. Albini & D.M. Noonan: Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr. Pharm. Des. 12, 3101-3115 (2006). (Pubitemid 44227572)
23. Mantovani A., B. Bottazzi, F. Colotta, S. Sozzani & L. Ruco: The origin and function of tumor associated macrophages. Immunol. Today 13, 265-270 (1992).
24. Mantovani A., T. Schioppa, C. Porta, P. Allavena, A. Sica: Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25:315-322 (2006). (Pubitemid 44922352)
25. Pollard J.W: Tumor-educated macrophages promote tumor progression and metastasis. Nat. Rev. Cancer 4, 71-78 (2004). (Pubitemid 38082155)
26. Bottazzi B., N. Polentarutti, R. Acero, A. Balsari, D. Boraschi, P. Ghezzi, M. Salmona, A. Mantovani : Regulation of the macrophage content of neoplasms by chemoattractans. Science 220, 210-212 (1983). (Pubitemid 13115270)
27. Polverini P. & S.J. Leibovich: Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab. Invest. 51, 635-642 (1984). (Pubitemid 15182529)
28. Richter G., S. Kruger-Krasagakes, G. Hein, C. Huls, E. Schmitt, T. Diamantstein, T. Blankenstein: Interleukin 10 gene transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. CancerRes 53, 4134- 4137 (1993). (Pubitemid 24146753)
29. Blankenstein T., Z. Qin, K. Überla, W. Müller, H. Rosen, H.D. Volk & T. Diamantstein: Tumor suppression after tumorcell-targeted tumor necrosis factor α gene transfer. J. Exp. Med. 173, 1047-1052 (1991).
30. Hock H., M. Dorsch, U. Kunzendorf, Z. Qin, T. Diamantstein & T. Blankenstein: Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin-2, interleukin-4, interleukin-7, tumor-necrosis factor, or interferon- γ. Proc. Natl. Acad. Sci. USA. 90, 2774-2778 (1993). (Pubitemid 23113499)
31. Crowther M., N.J. Brown, E.T. Bishop & C.E. Lewis: Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J. Leukocyte Biol. 70, 478-490 (2001). (Pubitemid 32954759)
32. Knowles H., R. Leek & A.L. Harris: Macrophage infiltration and angiogenesis in human malignancy. Novartis Foundation Symposium 256, 189-200 (2004).
33. Talks K.L., H. Turley, K.C. Gatter, P.H. Maxwell, C.W. Pugh, P.J. Ratcliffe & A.L. Harris: The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumorassociated macrophages. Am. J. Pathol 157, 411-421 (2000). (Pubitemid 30626905)
34. Hotchkiss K.A., A.W. Ashton, R.S. Klein, M.L. Lenzi, G.H. Zhu & E.L. Schwartz: Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res 63, 527-533 (2003). (Pubitemid 36152517)
35. Schoppmann S.F., P. Birner, J. Stöckl, R. Kalt, R. Ullrich, C. Caucig, E. Kriehuber, K. Nagy, K. Alitalo & D. Kerjaschki: Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol 161, 947-956 (2002). (Pubitemid 34988382)
36. Lin E.Y., A.V. Nguyen, R.G. Russell & J.W. Pollard: Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med 193, 727-740 (2001).
37. Mantovani A., S. Sozzani, M. Locati, P. Allavena & A. Sica: Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology 2002 23, 549-555 (2002). (Pubitemid 35223554)
38. Eubank T.D., M. Galloway, C.M. Montague, W.J. Waldman, C.B. Marsh: M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. J. Immunol 171, 2637-2643 (2003). (Pubitemid 37025577)
39. Hildenbrand R., I. Dilger, A. Horlin & H.J. Stutte: Urokinase and macrophages in tumour angiogenesis. Br. J. Cancer 72, 818-823 (1995).
40. Ishikawa S., H. Egami, T. Kurizaki, J. Akagi, Y. Tamori, N. Yoshida, X. Tan, N. Hayashi & M. Ogawa: Identification of genes related to invasion and metastasis in pancreatic cancer by cDNA representational difference analysis. J. Exp. Clin. Cancer Res 22, 299-306 (2003). (Pubitemid 36734189)
41. Klimetzek V. & C. Sorg: Lymphokine-induced secretion of plasminogen activator by murine macrophages. Eur. J. Immunol 7, 185-187 (1977). (Pubitemid 8070383)
42. Ahmed F., J. Wyckoff, E.Y. Lin, W. Wang, Y. Wang, L. Hennighausen, J. Miyazaki, J. Jones, J.W. Pollard, J.S. Condeelis & J.E. Segall: GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. Cancer Research 62, 7166-7169 (2001).
43. Goswami S., E. Sahai, J.B. Wyckoff, M. Cammer, D. Cox, F.J. Pixley, E.R. Stanley, J.E. Segall & J.S. Condeelis : Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 65, 5278-5283 (2005). (Pubitemid 40827339)
44. Kryczek I., S. Wei, L. Zou, G. Zhu, P. Mottram, H. Xu, L. Chen & W. Zou: Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J. Immunol. 177, 40-44 (2006). (Pubitemid 43939113)
45. Valmori D., F. Qian, M. Ayyoub, C. Renner, A. Merlo, S. Gnjatic, E. Stockert, D. Driscoll, S. Lele, L.J. Old & K. Odunsi: Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+T cells. Clin. Cancer Res 12, 398-404 (2006). (Pubitemid 43166127)
46. Wyckoff J., W. Wang, E.Y. Lin, Y. Wang, F. Pixley, E.R. Stanley, T. Graf, J.W. Pollard, J. Segall & J. Condeelis: A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64, 7022-7029 (2004). (Pubitemid 39331012)
47. Kryczek I., L. Zou, P. Rodriguez, G. Zhu, S. Wei, P. Mottram, M. Brumlik, P. Cheng, T. Curiel, L. Myers, A. Lackner, X. Alvarez, A. Ochoa, L. Chen & W. Zou: B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med 203, 871- 881 (2006).
48. Kryczek I., L. Zou, P. Rodriguez, G. Zhu, S. Wei, P. Mottram, M. Brumlik, P. Cheng, T. Curie, L. Myers, A. Lackner, X. Alvarez, A. Ochoa, L. Chen & W. Zou: B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. JEM 203, 871-881 (2007).
49. Galazka K, M. Opławski, W. Windorbska, J. Skret- Magierlo, K. Koper, P. Basta, P. Mach, M. Dutsch-Wicherek, A. Mazur & L. Wicherek: The immunohistochemical analysis of antigens such as RCAS1 and B7H4 in the cervical cancer nest and within the fibroblasts and macrophages infiltrating the cancer microenvironment. Am J Reprod Immunol 68, 85-93 (2012).
50. Gałazka K, L. Wicherek, K. Pitynski, J. Kijowski, K. Zajac, W. Bednarek, M. Dutsch-Wicherek, K. Rytlewski, J. Kalinka, A. Basta & M. Majka: Changes in the subpopulation of CD25+ CD4+ and FOXP3+ regulatory T cells in decidua with respect to the progression of labor at term and the lack of analogical changes in the subpopulation of suppressive B7-H4 macrophages-a preliminary report. Am J Reprod Immunol 61, 136-146 (2009).
51. Sonoda K., M. Nakashima, T. Kaku, T. Kamura, H. Nakano & T. Watanabe: A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 77, 1501-1509 (1996). (Pubitemid 26105386)
52. Nakashima M., K. Sonoda & T. Watanabe: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat. Med. 5, 928-942 (1999).
53. Sonoda K., S. Miyamoto, M. Nakashima & N. Wake: The biological role of the unique molecule RCAS1: A bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis. Front. Biosci. 13, 1106-1116 (2008). (Pubitemid 351594752)
54. Sonoda K. : Novel therapeutic strategies to target RCAS1, which induces apoptosis via ectodomain shedding. Histol Histopathol 26, 1475-1486 (2011).
55. Sonoda K., S. Miyamoto, M. Nakashima & N. Wake: Receptor-binding cancer antigen expressed on SiSo cells induces apoptosis via ectodomain shedding. Exp Cell Res. 316, 1795-1803 (2010).
56. Sonoda K., S. Miyamoto, H. Kobayashi, S. Ogawa, K. Okugawa, S. Taniguchi & N. Wake : The level of RCAS1 expression is inversely correlated with the number of vimentinpositive stromal cells in epithelial ovarian cancer. Int J Gynecol Cancer 19, 838-843 (2009).
57. Dutsch-Wicherek M. & L. Wicherek: The association of RCAS1 serum concentration with the reversibility or irreversibility of the process of immune cytotoxic activity restriction during normal menstrual cycle, cancer relapse, and surgical treatment for various types of squamous cell carcinomas and adenocarcinomas. Am J Reprod Immunol. 59, 266-275 (2008). (Pubitemid 351250427)
58. Wicherek Ł, P. Basta, K. Galazka, P. Mak, L. Dancewicz & J. Kalinka: RCAS1 decidual immunoreactivity and RCAS1 serum level during caesarean section with respect to the progression of labor. Am J Reprod Immunol 59, 152-158 (2008).
59. Skret-Magierło J, L. Wicherek, P. Basta, K. Galazka, J. Sikora, M. Wilk, L. Fudali & A. Skret: RCAS1 Decidual Immunoreactivity during Caesarean Section in Scar Deciduosis: Immune Cell Presence and Activity. Gynecol Obstet Invest 65, 187-194 (2008). (Pubitemid 351562921)
60. Wicherek L: Alterations in RCAS1 serum concentration levels during menstrual cycle in patients with uterine leiomyoma and lack of analogical changes in adenomyosis. Gynecol Obstet Invest 67, 195-201(2009).
61. Wicherek L.: The role of the endometrium in the regulation of immune cell activity. Front Biosci 13, 1018- 1035 (2008). (Pubitemid 351594745)
62. Wicherek L, K. Galazka & A. Lazar: The analysis of Metallothionein, RCAS1 immunoreactivity regarding immune cells concentration in endometrium and tubal mucosa in ectopic pregnancy during the course of tubal rupture. Gynecol Obstet Invest 65, 52-61(2008).
63. Wicherek L, K. Galazka & A. Lazar: RCAS1 Decidual Immunoreactivity During Placental Abruption: Immune Cell Presence and Activity. Am J Reprod Immunol 58, 46- 55 (2007). (Pubitemid 46939027)
64. Wicherek Ł, M. Klimek, J. Skret-Magierło, T. Banas, TJ. Popiela, J. Sikora, J. Kraczkowski, A. Czekierdowski, A. Skret & A. Basta: The obstetrical history in patients with Pfannenstiel scar endometriomas-an analysis of 81 patients. Gynecol Obstet Invest 63, 107-113(2007).
65. Suehiro Y., K. Muta, M. Nakashima, Y. Abe, M. Shiratsuchi, S. Shiokawa, S. Ikuyama, Y. Yoshikawa, T. Watanabe & J. Nishimura: A novel mechanism in suppression of erythropoiesis during inflammation: A crucial role of RCAS1. Eur. J. Haematol. 74, 365-373 (2005). (Pubitemid 40545560)
66. Matsushima T., N. Nakashima, K. Oshima, Y. Abe, J. Nishimura, H. Nawata, T. Watanabe & K. Muta: Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 15, 313-321 (2001).
67. Enjoji M.: RCAS1-expressing macrophages in inflammatory liver diseases. Liver International 26, 385-387 (2006). (Pubitemid 43349332)
68. Dutsch-Wicherek M, R. Tomaszewska, A. Lazar, L. Wicherek & J. Skladzien: The association between RCAS1 expression in laryngeal and pharyngeal cancer and its healthy stroma with cancer relapse. BMC Cancer 28, 9, 35(2009).
69. Dutsch-Wicherek M, A. Lazar & R. Tomaszewska: The Potential Role of MT and Vimentin Immunoreactivity in the Remodeling of the Microenvironment of Parotid Adenocarcinoma. Cancer Microenviron 4, 105-13 (2010).
70. Dutsch-Wicherek M, A. Lazar & R. Tomaszewska: The Involvement of RCAS1 in Creating a Suppressive Tumor Microenvironment in Patients with Salivary Gland Adenocarcinoma. Cancer Microenviron 4, 13-21 (2010).
71. Jozwicki W, W. Windorbska, AA. Brozyna, C. Jochymski, P. Basta, J. Sikora, E. Stasienko, M. Dutsch-Wicherek, K. Koper & L. Wicherek: The analysis of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) immunoreactivity within the microenvironment of the ovarian cancer lesion relative to the applied therapeutic strategy. Cell Tissue Res 345, 405-414 (2011).
72. Wicherek L, P. Basta, I. Wertel, Z. Kojs, B. Malkowski, M. Grabiec, M. Pietrus & K. Galazka: Analysis of RCAS1 immunoreactivity within hydatidiform mole cells and decidual cells according to the applied therapeutic strategy: surgery or surgery followed by chemotherapy. Gynecol Obstet Invest 73, 106-112 (2012).
73. Dutsch-Wicherek M, W. Windorbska, W. Jozwicki & H. Kazmierczak: The involvement of RCAS1 in creating a suppressive tumor microenvironment in patients with pharyngeal squamous cell carcinoma. Otolaryngol Pol 66, 49- 59. (2012).
74. Dutsch-Wicherek M, R. Tomaszewska, A. Lazar, P. Strek, L. Wicherek, J. Kijowski & M. MajkaL: The presence of B7- H4+ macrophages and CD25+CD4+ and FOXP3+ regulatory T cells in the microenvironment of nasal polyps - a preliminary report. Folia Histochem Cytobiol 48, 611-617 (2010).
75. Dutsch-Wicherek M, R. Tomaszewska, A. Lazar, P. Strek, L. Wicherek, K. Piekutowski & W. Jozwicki : The evaluation of metallothionein expression in nasal polyps with respect to immune cell presence and activity. BMC Immunology 11:10 (2010).
76. Acevedo V.D., R.D. Gangula, K.W. Freeman, R. Li, Y. Zhang, F. Wang, G.E. Ayala, L.E. Peterson, M. Ittmann & D.M. Spencer : Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-tomesenchymal transition. Cancer Cell 12, 559-571 (2007). (Pubitemid 350199071)
77. Hugo H., M.L. Ackland, T. Blick, M.G. Lawrence, J.A. Clements, E.D. Williams & E.W. Thompson: Epithelial- mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J. Cell. Physiol. 213, 374-383 (2007). (Pubitemid 47509716)
78. Xu J., R. Wang, Z.H. Xie, V. Odero-Marah, S. Pathak, A. Multani, L.W. Chung & H.E. Zhau: Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 66, 1664-1673 (2006). (Pubitemid 44646357)
79. Powell D.W., R.C. Mifflin, J.D. Valentich, S.E. Crowe, J.I. Saada & A.B. West: Myofibroblasts. I. Paracrine cells important in health and disease. Am. J. Physiol. 277, C1-C9. (1999).
80. Siegel P.M. & J. Massague: Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3: 807-882 (2003).
81. De Wever O. & M. Mareel: Role of tissue stroma in cancer cell invasion. J. Pathol. 200, 429-447 (2003). (Pubitemid 36818244)
82. Hayward S.W., Y. Wang, M. Cao, Y.K. Hom, B. Zhang, G.D. Grossfeld, D. Sudilovsky & G.R. Cunha: Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res. 2001; 61: 8135-8142 (2001). (Pubitemid 33091604)
83. Orimo A., P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson & R.A. Weinberg: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335- 348 (2005). (Pubitemid 40692295)
84. Cherian M.G., A. Jayasurya, B.H. Bay: Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat. Res. 33, 201-209 (2003). (Pubitemid 37487869)
85. Kagi J.H. & A. Scheffer: Biochemistry of metallothionein. Biochemistry 27, 8509-8515 (1998).
86. Apostolova M.D. & M.G. Cherian: Nuclear localization of metalothionein during cell proliferation and differentiation. Cell. Mol. Biol. 46, 347-356 (2000).
87. Fan L.Z., M.G. Cherian: Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. Br. J. Cancer 87, 1019-1026 (2002). (Pubitemid 35305656)
88. Dutsch-Wicherek M., T.J. Popiela, M. Klimek, L. Rudnicka-Sosin, L. Wicherek, J.P. Oudinet, J. Skladzien & R. Tomaszewska: Metallothionein stroma reaction in tumor adjacent healthy tissue in head and neck squamous cell carcinoma and breast adenocarcinoma. Neuro Endocrinol Lett. 26, 567-574 (2005). (Pubitemid 43013733)
89. Dutsch-Wicherek M., J. Sikora & R. Tomaszewska: The possible biological role of metallothionein in apoptosis. Front. Biosci. 13, 4029-4038 (2008). (Pubitemid 351599675)
90. Hellquist HB : Apoptosis in epithelial hyperplastic laryngeal lesions. Acta Otolaryngol. 527, 25-29 (1997). (Pubitemid 27241740)
91. Theocharis S.E., A.P. Margeli, J.T. Klijanienko & G.P. Kouraklis: Metallothionein expression in human neoplasia. Histopathology 45, 103-118 (2004). (Pubitemid 39120406)
92. Popiela T.J., L. Rudnicka-Sosin, M. Dutsch-Wicherek, M. Klimek, P. Basta, K. Galazka & L. Wicherek: The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity. Neuro Endocrinol Lett 27, 786-794 (2006). (Pubitemid 46138640)
93. Popiela T.J., M. Klimek, L. Wicherek, M. Dutsch- Wicherek, K. Galazka & L. Rudnicka-Sosin: The characterization of the exposure to immune mediated apoptosis and the regulation of immune cytotoxic activity in the environment of a neoplasm and in decidua. Neuro Endocrinol Lett 27, 779-785 (2006). (Pubitemid 46138639)
94. Acevedo V.D., R.D. Gangula, K.W. Freeman, R. Li, Y. Zhang, F. Wang, G.E. Ayala, L.E. Peterson, M. Ittmann & D.M. Spencer: Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-tomesenchymal transition. Cancer Cell 12, 559-571 (2007). (Pubitemid 350199071)
95. Hugo H., M.L. Ackland, T. Blick, M.G. Lawrence, J.A. Clements, E.D. Williams & E.W. Thompson: Epithelial- mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J. Cell. Physiol. 213, 374-383 (2007). (Pubitemid 47509716)
96. Xu J., R. Wang, Z.H. Xie, V. Odero-Marah, S. Pathak, A. Multani, L.W. Chung & H.E. Zhau: Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis. Prostate 66, 1664-1673 (2006). (Pubitemid 44646357)
97. Assioan RK: Anchorage - dependent cell cycle progression. Mini-review. J. Cell. Biology 136, 1-4 (1997).
98. Pennacchietti S., P. Michieli, M. Galluzzo, M. Mazzone, S. Giordano & P.M. Comoglio: Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347-361 (2003). (Pubitemid 38340304)
99. Rytomaa M., K. Lehmann & J. Downward: Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Rafsignalling. Oncogene 9, 4461-4468 (2000).
100. Frisch S.M. & R.A. Screaton: Anoikis mechanisms. Curr. Opin. Cell. Biol. 13, 555-562 (2001). (Pubitemid 32817013)
101. Cooper C.R. & K.J. Pienta: Cell adhesion and chemotaxis in prostate cancer metastasis to bone: A minireview. Prostate Cancer Prostatic Dis. 3, 6-12 (2000). (Pubitemid 30616513)
102. Torer N., F. Kayaselcuk, T.Z. Nursal, S. Yildirim, A. Tarim, T. Nòyan & H. Karakayali: Adhesion molecules as prognostic markers in pancreatic adenocarcinoma. J. Surg. Oncol. 96, 419-423 (2007). (Pubitemid 47519448)
103. Skubitz A.P. : Adhesion molecules. Cancer Treat. Res.107, 305-329 (2002).
104. Geiger B. & O. Ayalon : Cadherins. Ann. Rev. Cell. Biol. 8, 307-332 (1992).
105. Cavallaro U. & G. Christofori: Cell adhesion and signaling by cadherins and Ig- AMs in cancer. Nat. Rev. Cancer 4, 118-132 (2004). (Pubitemid 38198740)
106. Hirohashi S.: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol. 153, 333- 339 (1998). (Pubitemid 28373643)
107. Kokkinos M.I., R. Wafai, M.K. Wong, D.F. Newgreen, E.W. Thompson & M. Waltham: Vimentin and epithelialmesenchymal transition in human breast cancer - observations in vitro and in vivo. Cells Tissues Organs 185, 191-203 (2007). (Pubitemid 46957486)
108. Devkota B., M. Sasaki, M. Matsui, C. Amaya Montoya & Y. Miyake: Alterations in the immunohistochemical localization patterns of alpha-smooth muscle actin (SMA) and vimentin in the postnatally developing bovine cryptorchid testis. J. Reprod. Dev. 52, 329-334 (2006). (Pubitemid 43979599)
109. Carter V., B.K. Shenton, B. Jaques, D. Turner, D. Talbot, A. Gupta, C.E. Chapman, C.J. Matthews & G. Cavanagh: Vimentin antibodies: A non-HLA antibody as a potential risk factor in renal transplantation. Transplant Proc. 37, 654-657 (2005). (Pubitemid 40590660)
110. Helfand B.T., L. Chang & R.D. Goldman: Intermediate filaments are dynamic and motile elements of cellular architecture. J. Cell Sci. 117, 133-141 (2004). (Pubitemid 38128894)
111. Grunert S., M. Jechlinger & H. Beug: Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell. Biol. 4, 657-665 (2003). (Pubitemid 36934968)
112. Tarin D., E.W. Thompson & D.F. Newgreen: The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res. 65, 5996-6000 (2005). (Pubitemid 40994379)
113. Barrallo-Gimeno A. & M.A. Nieto: The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132, 3151-3161 (2005). (Pubitemid 41167144)
114. Peinado H., F. Portillo & A. Cano: Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 48, 365-375 (2004). (Pubitemid 39360388)
115. Kang Y. & J. Massague: Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118, 277- 279 (2004). (Pubitemid 39061108)
116. Lu Z., S. Ghosh, Z. Wang & T. Hunter:. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4, 499-515 (2003). (Pubitemid 38050046)
117. Strathdee G.: Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin. Cancer Biol. 12, 373-379 (2002).
118. Morali O.G., V. Delmas, R. Moore, C. Jeanney, J.P. Thiery & L. Larue L: IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 20, 4942-4950 (2001). (Pubitemid 32769784)
119. Peng Y.F., K. Mandai, H. Nakanishi, W. Ikeda, M. Asada, Y. Momose, S. Shibamoto, K. Yanagihara, H. Shiozaki, M. Monden, M. Takeichi & Y. Takai: Restoration of E-cadherin-based cell-cell adhesion by overexpression of nectin in HSC-39 cells, a human signet ring cell gastric cancer cell line. Oncogene 21, 4108-4119 (2002). (Pubitemid 34712878)
120. McCawley L.J., P. O'Brien & L.G. Hudson: Epidermal growth factor (EGF)- and scatter factor/hepatocyte growth factor (SF/HGF)- mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)- 9. J. Cell Physiol. 176, 255-265 (1998). (Pubitemid 28319709)
121. Cavallaro U. & G. Christofori: Cell adhesion and signaling by cadherins and Ig- AMs in cancer. Nat. Rev. Cancer 4, 118-132 (2004). (Pubitemid 38198740)
122. Suyama K., I. Shapiro, M. Guttman & R.B. Hazan: A signaling pathway leading to metastasis is controlled by Ncadherin and the FGF receptor. Cancer Cell 2, 301-314 (2002). (Pubitemid 41043964)
123. Eger A., A. Stockinger, J. Park, E. Langkopf, M. Mikula, J. Gotzmann, W. Mikulits, H. Beug & R. Foisner: beta-Catenin and TGFbetasignalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene 23, 2672-2680 (2004). (Pubitemid 38586321)
124. Paccione R.J., H. Miyazaki, V. Patel, A. Waseem, J.S. Gutkind, Z.E. Zehner & W.A. Yeudall: Keratin downregulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility. Mol. Cancer Ther. 7: 2894-2903 (2008).
125. Mandal M., J.N. Myers, S.M. Lippman, F.M. Johnson, M.D. Williams, S. Rayala, K. Ohshiro, D.I. Rosenthal, R.S. Weber, G.E. Gallick & A.K. El-Naggar: Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 112, 2088-2100 (2008). (Pubitemid 351574086)